Consolidation Chemotherapy
"Consolidation Chemotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug treatment designed to further diminish the disease toward complete remission following INDUCTION CHEMOTHERAPY. It helps to consolidate the gains during induction chemotherapy and may be followed by MAINTENANCE CHEMOTHERAPY.
Descriptor ID |
D060830
|
MeSH Number(s) |
E02.319.218
|
Concept/Terms |
Consolidation Chemotherapy- Consolidation Chemotherapy
- Chemotherapies, Consolidation
- Chemotherapy, Consolidation
- Consolidation Chemotherapies
|
Below are MeSH descriptors whose meaning is more general than "Consolidation Chemotherapy".
Below are MeSH descriptors whose meaning is more specific than "Consolidation Chemotherapy".
This graph shows the total number of publications written about "Consolidation Chemotherapy" by people in this website by year, and whether "Consolidation Chemotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 2 | 1 | 3 |
2018 | 3 | 2 | 5 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Consolidation Chemotherapy" by people in Profiles.
-
Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics. J Clin Pharmacol. 2021 08; 61(8):1096-1105.
-
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). Bull Cancer. 2021 May; 108(5):490-500.
-
Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic. Oncology (Williston Park). 2020 09 15; 34(9):370-376.
-
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. J Clin Oncol. 2019 12 01; 37(34):3212-3222.
-
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC). Clin Lung Cancer. 2019 01; 20(1):43-47.
-
Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients. Transfus Apher Sci. 2018 Dec; 57(6):752-755.
-
Cutaneous herald: leukaemia cutis as presenting manifestation of relapse in acute promyelocytic leukaemia. BMJ Case Rep. 2018 May 02; 2018.
-
Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. Immunotherapy. 2018 06; 10(8):699-711.
-
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia. J Thromb Thrombolysis. 2018 Feb; 45(2):306-314.
-
Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk. Bone Marrow Transplant. 2018 02; 53(2):228-230.